• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从 7-氮杂吲哚到腺嘌呤:含去氮杂腺嘌呤配体的铜(II)配合物的混合配体分子识别方面。

From 7-azaindole to adenine: molecular recognition aspects on mixed-ligand Cu(II) complexes with deaza-adenine ligands.

机构信息

Department of Inorganic Chemistry, Faculty of Pharmacy, University of Granada, Campus Cartuja s/n, 18071 Granada, Spain.

出版信息

Dalton Trans. 2013 May 7;42(17):6119-30. doi: 10.1039/c2dt32191b.

DOI:10.1039/c2dt32191b
PMID:23324859
Abstract

For a better understanding of the versatile behaviour of adenine as a ligand, a series of 10 ternary copper(II) complexes with deaza-adenine ligands [7-azaindole (1,6,7-trideaza-adenine, H7azain), 4-azabenzimidazole (1,6-dideaza-adenine, H4abim), 5-azabenzimidazole (3,6-dideaza-adenine, H5abim), and 7-deaza-adenine (H7deaA)] have been synthesised and characterised by X-ray diffraction. Likewise, all the compounds studied have been analysed by spectral and thermal methods. The proton tautomers and donor capabilities of the above-mentioned deaza-adenine ligands have been calculated by DFT. We conclude that the increasing presence of N-donors in deaza-adenine ligands favours the proton tautomerism and their versatility as co-ligands. Notably, H7azain consistently uses the same tautomer, H4abim uses two different tautomers but is not protonated by the pentadentate H(2)EDTA(2-) ligand, and H(N1)5abim displays the μ(2)-N7,N9 mode, whereas H(N9)7deaA binds Cu(II) by N3 in cooperation with an intra-molecular N9-H···O interaction or using the unprecedented bidentate μ(2)-N1,N3 bridging mode.

摘要

为了更好地理解腺嘌呤作为配体的多功能性,我们合成了一系列 10 种与去氮腺嘌呤配体的三元铜(II)配合物[7-氮杂吲哚(1,6,7-三氮杂腺嘌呤,H7azain)、4-氮杂苯并咪唑(1,6-二氮杂腺嘌呤,H4abim)、5-氮杂苯并咪唑(3,6-二氮杂腺嘌呤,H5abim)和 7-脱氮腺嘌呤(H7deaA)],并用 X 射线衍射进行了表征。同样,我们还通过光谱和热方法分析了所有研究的化合物。通过 DFT 计算了上述去氮腺嘌呤配体的质子互变异构体和供体能力。我们得出的结论是,去氮腺嘌呤配体中 N-供体的增加有利于质子互变异构体及其作为共配体的多功能性。值得注意的是,H7azain 始终使用相同的互变异构体,H4abim 使用两种不同的互变异构体,但不会被五齿 H(2)EDTA(2-)配体质子化,而 H(N1)5abim 显示 μ(2)-N7,N9 模式,而 H(N9)7deaA 则通过 N3 与 Cu(II)配位,同时通过分子内 N9-H···O 相互作用或使用前所未有的双齿 μ(2)-N1,N3 桥接模式。

相似文献

1
From 7-azaindole to adenine: molecular recognition aspects on mixed-ligand Cu(II) complexes with deaza-adenine ligands.从 7-氮杂吲哚到腺嘌呤:含去氮杂腺嘌呤配体的铜(II)配合物的混合配体分子识别方面。
Dalton Trans. 2013 May 7;42(17):6119-30. doi: 10.1039/c2dt32191b.
2
Structural consequences of the N7 and C8 translocation on the metal binding behavior of adenine.N7 和 C8 易位对腺嘌呤金属结合行为的结构影响。
Inorg Chem. 2013 Feb 18;52(4):1916-25. doi: 10.1021/ic302147u. Epub 2013 Jan 28.
3
Molecular recognition modes between adenine or adeniniun(1+) ion and binary M(II)(pdc) chelates (MCoZn; pdc=pyridine-2,6-dicarboxylate(2-) ion).腺嘌呤或腺嘌呤离子与二元 M(II)(pdc)螯合物(MCoZn;pdc=吡啶-2,6-二羧酸根离子(2-))之间的分子识别模式。
J Inorg Biochem. 2013 Oct;127:211-9. doi: 10.1016/j.jinorgbio.2013.06.008. Epub 2013 Jun 21.
4
Structural insights on the molecular recognition patterns between N(6)-substituted adenines and N-(aryl-methyl)iminodiacetate copper(II) chelates.关于 N(6)-取代腺嘌呤和 N-(芳基-甲基)亚氨基二乙酸铜(II)螯合物之间分子识别模式的结构见解。
J Inorg Biochem. 2013 Oct;127:141-9. doi: 10.1016/j.jinorgbio.2013.02.002. Epub 2013 Feb 15.
5
Interligand interactions controlling the mu-N7,N9-metal bonding of adenine (AdeH) to the N-benzyliminodiacetato(2-) copper(II) chelate and promoting the N9 versus N3 tautomeric proton transfer: molecular and crystal structure of [Cu2(NBzIDA)(2)(H2O)(2)(mu-N7,N9-Ade(N3)H)].(3)H2O.配体间相互作用控制腺嘌呤(AdeH)与N - 苄基亚氨基二乙酸根(2 - )铜(II)螯合物的μ - N7,N9 - 金属键合并促进N9与N3互变异构质子转移:[Cu2(NBzIDA)(2)(H2O)(2)(μ - N7,N9 - Ade(N3)H)]·(3)H2O的分子和晶体结构
Inorg Chem. 2002 Dec 2;41(24):6190-2. doi: 10.1021/ic025881k.
6
One-dimensional oxalato-bridged Cu(II), Co(II), and Zn(II) complexes with purine and adenine as terminal ligands.以嘌呤和腺嘌呤作为端基配体的一维草酸根桥联铜(II)、钴(II)和锌(II)配合物。
Inorg Chem. 2004 Sep 6;43(18):5761-70. doi: 10.1021/ic049569h.
7
A tetranuclear Cu(II)-based 2D aggregate with an unprecedented tetradentate mu(4)-N1,N3,N7,N9-adeninate nucleobase.一种基于四核铜(II)的二维聚集体,带有前所未有的四齿μ(4)-N1、N3、N7、N9-腺嘌呤核碱基。
Inorg Chem. 2009 Apr 20;48(8):3511-3. doi: 10.1021/ic900113e.
8
Intrinsic acid-base properties of purine derivatives in aqueous solution and comparison of the acidifying effects of platinum(II) coordinated to N1 or N7: acidifying effects are reciprocal and the proton "outruns" divalent metal ions.嘌呤衍生物在水溶液中的固有酸碱性质以及与N1或N7配位的铂(II)的酸化作用比较:酸化作用是相互的,且质子“超过”二价金属离子。
Inorg Chem. 2003 Jan 13;42(1):32-41. doi: 10.1021/ic020535o.
9
Molecular recognition between adenine or 2,6-diaminopurine and copper(II) chelates with N,O2,S-tripodal tetradentate chelators having thioether or disulfide donor groups.腺嘌呤或2,6 - 二氨基嘌呤与含有硫醚或二硫键供体基团的N,O2,S - 三脚架四齿螯合剂的铜(II)螯合物之间的分子识别。
J Inorg Biochem. 2015 Oct;151:75-86. doi: 10.1016/j.jinorgbio.2015.05.014. Epub 2015 Jun 3.
10
Supramolecular architectures assembled by the interaction of purine nucleobases with metal-oxalato frameworks. Non-covalent stabilization of the 7H-adenine tautomer in the solid-state.由嘌呤核碱基与金属草酸盐框架相互作用组装而成的超分子结构。固态中7H-腺嘌呤互变异构体的非共价稳定化。
Dalton Trans. 2006 Feb 21(7):902-11. doi: 10.1039/b510018f. Epub 2005 Dec 5.

引用本文的文献

1
Silver Binding Dichotomy for 7-Deazaadenine/Thymine: Preference for Watson-Crick Pairing over Homobase Interactions in DNA.7-脱氮腺嘌呤/胸腺嘧啶的银结合二分法:在DNA中对沃森-克里克配对的偏好超过同碱基相互作用。
Inorg Chem. 2025 Jul 21;64(28):14455-14465. doi: 10.1021/acs.inorgchem.5c01762. Epub 2025 Jul 10.
2
Nearest-neighbor parameters for 7-deaza-adenosine·uridine base pairs in RNA duplexes.RNA双链体中7-脱氮腺苷·尿苷碱基对的最近邻参数。
RNA. 2016 Jun;22(6):934-42. doi: 10.1261/rna.055277.115. Epub 2016 Apr 20.
3
Homoleptic transition metal complexes of the 7-azaindolide ligand featuring κ(1)-N1 coordination.
具有κ(1)-N1配位的7-氮杂吲哚配体的均配过渡金属配合物。
Inorg Chem. 2015 Oct 5;54(19):9637-9645. doi: 10.1021/acs.inorgchem.5b01732. Epub 2015 Sep 17.